Evidence map›Paper›PMID 33029096›Full record

ReviewInternational journal of medical sciences2020

Guanidinoacetic acid deficiency: a new entity in clinical medicine?

Sergej M Ostojic, Laszlo Ratgeber, Andras Olah, Jozsef Betlehem, Pongras Acs

Open access · goldAbstract readReview
In one paragraph

Review in International journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Long COVID: Is there a kidney link?Frontiers in medicine · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sergej M OstojicFSPE Applied Bioenergetics Lab, University of Novi Sad, Novi Sad, Serbia.
Laszlo RatgeberFaculty of Health Sciences, University of Pecs, Pecs, Hungary.
Andras OlahFaculty of Health Sciences, University of Pecs, Pecs, Hungary.
Jozsef BetlehemFaculty of Health Sciences, University of Pecs, Pecs, Hungary.
Pongras AcsFaculty of Health Sciences, University of Pecs, Pecs, Hungary.
University of Pecs · HUUniversity of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guanidinoacetic acid (GAA, also known as glycocyamine or betacyamine) is a naturally-occurring derivative of glycine and a direct metabolic precursor of creatine, a key player in high-phosphate cellular bioenergetics. GAA is found in human serum and urine, with circulating GAA likely reflects an equilibrium between its endogenous production and utilization/excretion. GAA deficiency (as indicated by low serum GAA) has been reported in various conditions yet this intriguing clinical entity appears to be poorly characterized as yet, either as a primary deficit or a sequel of secondary disease. This minireview article summarizes the inherited and acquired disorders with apparent GAA deficiency and discusses a possible relevance of GAA shortfall in clinical medicine.

Indexed as

CreatineEnergy MetabolismGlycineHumansMetabolic DiseasesCreatineGlycineglycocyamineAGAT deficiencyepilepsyguanidinoacetic acidrenal failuretraumatic injury

Identifiers

PMID33029096
PMCPMC7532483
OpenAlexW3087912778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.